trending Market Intelligence /marketintelligence/en/news-insights/trending/mv62fxck08p4iituicby6a2 content
Log in to other products

Login to Market Intelligence Platform


Looking for more?

Contact Us

Request a Demo

You're one step closer to unlocking our suite of comprehensive and robust tools.

Fill out the form so we can connect you to the right person.

  • First Name*
  • Last Name*
  • Business Email *
  • Phone *
  • Company Name *
  • City *
  • We generated a verification code for you

  • Enter verification Code here*

* Required

In this list

Aflac resembles P&C insurer, says Macquarie

CUSIP Identifier Requests for New U.S. Corporate Debt Surge in January

Measuring The Wireline Digital Divide In The US

West Africa Mining By The Numbers

Australian Exploration Budget Trends 2019

Aflac resembles P&C insurer, says Macquarie

Macquarie analyst Sean Dargan on April 14 raised hisinvestment opinion on AflacInc. to "outperform" from "neutral," and raisedhis price target to $76 from $63.

"With solid underwriting margins in Japan, we believeAflac does not need sales growth at any costs nor does it need help frominterest rates to generate superior unlevered returns on capital forshareholders," he wrote. In that regard, the company more closelyresembles a P&C insurer.

The growing demand of third sector insurance products, whichcomprise cancer, medical and long-term care insurance, in Japan as well asAflac's position as a market leader in that line of business there, presents agreat growth opportunity for the insurer, according to Dargan.

Dargan raised his 2016 EPS estimate to $6.55 from $6.35,2017 EPS estimate to $6.90 from $6.75 and 2018 EPS estimate to $7.30 from $7.05.